PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 108 filers reported holding PROVENTION BIO INC in Q4 2020. The put-call ratio across all filers is 3.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $85,000 | -38.8% | 3,549 | -72.9% | 0.00% | – |
| Q4 2022 | $139,000 | +297.1% | 13,089 | +68.5% | 0.00% | – |
| Q3 2022 | $35,000 | +218.2% | 7,769 | +166.5% | 0.00% | – |
| Q2 2022 | $11,000 | -78.4% | 2,915 | -58.7% | 0.00% | – |
| Q1 2022 | $51,000 | -23.9% | 7,064 | -40.9% | 0.00% | – |
| Q4 2021 | $67,000 | +55.8% | 11,959 | +77.3% | 0.00% | – |
| Q3 2021 | $43,000 | -21.8% | 6,744 | +3.2% | 0.00% | – |
| Q2 2021 | $55,000 | +14.6% | 6,534 | +44.9% | 0.00% | – |
| Q1 2021 | $48,000 | +220.0% | 4,508 | +407.1% | 0.00% | – |
| Q4 2020 | $15,000 | +36.4% | 889 | 0.0% | 0.00% | – |
| Q3 2020 | $11,000 | -21.4% | 889 | -7.4% | 0.00% | – |
| Q2 2020 | $14,000 | +180.0% | 960 | +92.0% | 0.00% | – |
| Q1 2020 | $5,000 | -64.3% | 500 | -47.4% | 0.00% | – |
| Q4 2019 | $14,000 | +40.0% | 950 | -39.4% | 0.00% | – |
| Q3 2019 | $10,000 | – | 1,567 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 217,050 | $2,278,000 | 1.60% |
| Perceptive Advisors | 2,852,058 | $29,932,000 | 0.38% |
| 683 Capital Management, LLC | 630,000 | $6,612,000 | 0.35% |
| ADVISORY RESEARCH INC | 237,500 | $2,493,000 | 0.18% |
| GILDER GAGNON HOWE & CO LLC | 3,109,874 | $32,638,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,195 | $2,594,000 | 0.08% |
| Virtus ETF Advisers LLC | 16,158 | $170,000 | 0.07% |
| Walleye Capital LLC | 103,823 | $1,090,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 22,755 | $239,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 29,384 | $308,000 | 0.05% |